1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Ixekizumab
Trade Name:
Taltz
Manufacturer/Distributor:
Eli Lilly Canada
Classification:
Immunomodulator
ATC Class:
L04AC13 - Ixekizumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2016/05/25
Date Marketed in Canada (yyyy/mm/dd):
2018/03/29
Presentation:
Solution for injection: 80 mg/1 mL. DIN: 02455102
Comments:
For treatment of active psoriatic arthritis in patients who have responded inadequately to, or are intolerant to one or more DMARDs. It can be used alone or in combination with a conventional DMARD (e.g. methotrexate).
Back to:
Drug Product Listings 
